Workflow
Beingmate(002570)
icon
Search documents
贝因美(002570) - 2022 Q4 - 年度财报(更正)
2025-04-28 19:15
Financial Performance - The company's operating revenue for 2022 was ¥2,509,171,932.67, representing a 6.98% increase compared to ¥2,345,458,993.11 in 2021[21]. - The net profit attributable to shareholders was -¥175,996,805.92 in 2022, a decrease of 340.06% from ¥73,314,574.33 in 2021[21]. - The net cash flow from operating activities increased by 52.96% to ¥377,416,659.60 in 2022, up from ¥246,743,802.53 in 2021[21]. - The basic earnings per share for 2022 was -¥0.16, a decline of 328.57% from ¥0.07 in 2021[21]. - Total assets at the end of 2022 were ¥3,877,108,863.41, down 4.73% from ¥4,069,421,166.85 at the end of 2021[21]. - The net assets attributable to shareholders decreased by 13.84% to ¥1,538,639,572.79 at the end of 2022, compared to ¥1,785,836,479.80 at the end of 2021[21]. - The company reported a significant drop in net profit after deducting non-recurring gains and losses, with a figure of -¥212,862,617.24 in 2022 compared to ¥7,296,140.06 in 2021, a decrease of 3,017.47%[21]. - The gross profit margin decreased to 45.88%, down by 4.93 percentage points compared to the previous year, primarily due to increased sales discounts and rising raw material prices[50]. Market and Product Development - The company reported a significant decline in newborn numbers, impacting the infant formula market, and plans to leverage existing resources to expand market presence and sales scale[4]. - The company is operating in a favorable environment for the maternity and infant industry, supported by government policies encouraging childbirth and reducing childcare costs[31]. - The main product category, infant formula, generated a revenue of 2.276 billion yuan, with a year-on-year increase of 7.55%[36]. - The infant formula market in China is expected to see significant growth as demand shifts from first and second-tier cities to third and fourth-tier cities[38]. - The company is focusing on enhancing its R&D capabilities and has a strong pipeline of new products to meet consumer demands[39]. - The company has completed the registration of 10 key series and 30 products under the new national standards, with ongoing registration for other products[38]. Corporate Governance and Management - The company’s financial report is guaranteed to be true, accurate, and complete by its management team, ensuring accountability[4]. - The company has established a robust information disclosure system, ensuring timely and accurate communication with investors through designated platforms[110]. - The company is committed to enhancing corporate governance by adhering to relevant laws and regulations, thereby protecting the rights of minority shareholders[105]. - The company has implemented performance evaluation and incentive mechanisms to ensure accountability and motivation among its management[111]. - The company maintains independence from its controlling shareholder, ensuring no interference in decision-making processes[107]. - The company has established a fair and transparent performance evaluation and incentive mechanism for senior management[112]. Financial Management and Investments - The company will not distribute cash dividends or issue bonus shares, focusing on reinvestment for growth[7]. - The company has committed to invest a total of 120,000,000 CNY, with 25,230,460 CNY already invested, achieving a progress rate of 21.02%[90]. - The company raised a total of ¥258,854,998.50 from a private placement, with a net amount of ¥252,304,573.30 after deducting issuance costs[86]. - The company has significant restricted assets totaling ¥1,109,258,502.25, primarily due to loan collateral[80]. - The company has not reported any major asset or equity sales during the reporting period[93][94]. Operational Challenges and Risks - The company’s net profit turned from profit to loss in 2022 due to various operational challenges, but it continues to pursue growth opportunities[36]. - The company is aware of potential food safety risks and maintains a high standard of quality control throughout the production process[6]. - The company reported a significant decrease in sales volume for other products, down 76.04% year-on-year, attributed to a sharp decline in new orders[56]. - The company is facing a pending economic dispute involving a sales contract with a claim amount of 1.28 million, currently in the execution phase[188]. Social Responsibility and Environmental Impact - The company donated over 2.6 million yuan to various charitable organizations during the reporting period[167]. - The company has been actively involved in social responsibility initiatives, including the "Love Baby" and "Parenting" projects, since 1993[167]. - The company has implemented clean production practices and has passed certifications for clean production, energy management, and environmental management systems[166]. - The company and its subsidiaries are not classified as key pollutant discharge units by local environmental authorities[165]. Shareholder Engagement and Meetings - The company held three shareholder meetings during the reporting period, ensuring equal treatment of all shareholders and facilitating their rights[106]. - The participation rate of investors in the 2022 first extraordinary general meeting was 24.68%[117]. - The board of directors convened eight meetings, with a composition of 8 members, including 3 independent directors, complying with legal and regulatory requirements[108]. Related Party Transactions and Compliance - The company engaged in related party transactions amounting to 24.38 million, accounting for 53.50% of similar transactions, with a total approved limit of 22 million[191]. - The company has frozen 53 million shares, representing 26.98% of the total shares held by its controlling shareholder, due to a court enforcement application[190]. - The company has implemented corrective measures for the identified control deficiencies[162].
贝因美(002570) - 2024 Q2 - 季度财报(更正)
2025-04-28 19:15
Financial Performance - The company's revenue for the first half of 2024 reached approximately ¥1.42 billion, representing a 5.61% increase compared to ¥1.34 billion in the same period last year[19]. - Net profit attributable to shareholders increased by 16.41% to approximately ¥51.54 million, up from ¥44.27 million in the previous year[19]. - The net profit after deducting non-recurring gains and losses rose by 39.50% to approximately ¥38.52 million, compared to ¥27.61 million in the same period last year[19]. - Basic earnings per share increased by 25.00% to ¥0.05, up from ¥0.04 in the same period last year[19]. - The gross profit margin for the main business was 42.27%, with a year-on-year increase of 5.39% in main business income[35]. - The company achieved a revenue of CNY 1.42 billion in the first half of 2024, representing a year-on-year growth of 5.61%[45]. - The sales volume of milk powder increased by 36.59% year-on-year, reaching 13,671.91 tons, while production volume rose by 28.08% to 14,188.21 tons[39]. - The company reported a significant increase in sales volume for rice flour products, which surged by 185.46% year-on-year to 831.85 tons[40]. - The company reported a net investment of ¥58,867,247.06 during the reporting period, a 47.51% increase compared to the previous year[60]. - The company reported a total revenue of 1,772.84 million yuan for the period, with a significant portion attributed to transactions with its parent company[97]. Cash Flow and Financial Position - The company's operating cash flow net amount was approximately ¥201.51 million, reflecting a 13.89% increase from ¥176.94 million in the previous year[19]. - Cash and cash equivalents decreased by 79.95% to ¥20,035,032.32, primarily due to lower net cash flow from operating activities[48]. - The company's total assets at the end of the reporting period were approximately ¥3.80 billion, a decrease of 4.98% from ¥4.00 billion at the end of the previous year[19]. - The company’s financial expenses surged by 106.51% to CNY 22.56 million, mainly due to exchange losses[47]. - The ending balance of cash and cash equivalents increased to CNY 847,654,034.78 from CNY 706,551,066.00 year-over-year[153]. - The total liabilities decreased to CNY 2,217,204,671.72 from CNY 2,360,257,511.45, a decrease of approximately 6.0%[138]. - The company’s total assets at the end of the first half of 2024 are CNY 2,657,696,070.65, compared to CNY 2,707,821,154.64 at the end of the first half of 2023, reflecting a decrease of about 1.9%[162]. Product Development and Market Strategy - The company has completed the second formula registration for its major products, including "Beingmate Aijia," "Keruixin," and "Jingai" infant formula[26]. - The company is actively developing new products in the fields of nutritional rice flour and adult milk powder, expanding its product offerings in maternal and infant nutrition[26]. - The company plans to strengthen its presence in the maternal and infant products market through brand licensing and innovative product development[26]. - The company has established a data platform to empower terminal operations, focusing on personalized nutrition and precise formulation technology to drive high-quality development in the nutrition industry[27]. - The company has successfully completed global brand certification on Amazon, expanding its product offerings into the North American market[27]. - The company aims to enhance brand visibility through collaborations and media campaigns, focusing on creating popular products to drive sales[71]. Operational Efficiency and Management - The company has restructured its management and marketing strategies, enhancing operational efficiency and laying a solid foundation for future performance growth[27]. - The company is committed to improving operational efficiency and reducing costs through systematic improvements and information technology integration[71]. - The company plans to continue optimizing its organizational structure and reforming its compensation system to enhance team effectiveness and shareholder value[72]. - The company has implemented a long-term talent assessment and planning system to align employee interests with those of shareholders[72]. Shareholder and Corporate Governance - The company did not distribute cash dividends or issue bonus shares for the half-year period, nor did it increase capital through reserves[77]. - A total of 782 employees participated in the employee stock ownership plan, holding a total of 8,380,030 shares, representing 0.78% of the company's total equity[80]. - The company held its first temporary shareholders' meeting on January 30, 2024, with an investor participation rate of 28.69%[75]. - The annual shareholders' meeting on May 21, 2024, had a participation rate of 23.08%[75]. - The company has undergone a change in its board and management personnel, with several new appointments effective May 21, 2024[76]. Social Responsibility and Community Engagement - The company has been focused on the infant and child sector since its establishment in 1992, emphasizing the importance of maternal happiness and successful child-rearing as its core value[84]. - The company has initiated three major social welfare projects: "Love Baby Project," "育婴工程" (Child Rearing Project), and "亲母工程" (Mother Care Project) to support families and promote healthy growth for children[85]. - The company emphasizes the importance of scientific and safe products and services in the infant and child industry as a key social responsibility[85]. - The company has actively engaged in promoting parent-child culture through international forums and discussions, enhancing awareness of traditional Chinese parenting culture[85]. Risks and Challenges - The company faces risks from declining birth rates, which could weaken demand in the infant product market, necessitating strategic adjustments[70]. - To counteract market changes, the company plans to develop a new product matrix targeting adult nutrition needs and expand its marketing strategies[71]. Compliance and Regulatory Matters - The company has not faced any environmental penalties during the reporting period and has maintained compliance with environmental regulations[83]. - The company reported no significant litigation or arbitration matters during the reporting period[92]. - The company has no violations regarding external guarantees during the reporting period[89]. - The company has not experienced any bankruptcy restructuring matters during the reporting period[91].
贝因美(002570) - 2025 Q1 - 季度财报
2025-04-28 19:15
Financial Performance - Revenue for Q1 2025 was CNY 727.74 million, a 1.01% increase compared to CNY 720.46 million in the same period last year[5] - Net profit attributable to shareholders increased by 93.87% to CNY 42.80 million from CNY 22.07 million year-on-year[5] - Operating cash flow net amount rose by 101.53% to CNY 166.42 million, compared to CNY 82.58 million in the previous year[5] - Basic earnings per share doubled to CNY 0.04 from CNY 0.02 in the same period last year[5] - Total operating revenue for the current period reached ¥727,744,363.89, a slight increase from ¥720,455,358.38 in the previous period, representing a growth of approximately 0.18%[33] - Operating profit increased to ¥51,460,138.11, compared to ¥28,986,831.76 in the previous period, marking a growth of approximately 77.4%[34] - Net profit for the current period was ¥45,483,601.85, up from ¥24,465,526.74, indicating an increase of around 85.9%[34] - The net profit attributable to the parent company was CNY 42,796,120.16, an increase of 93.5% compared to CNY 22,074,986.63 in the previous period[35] - The total comprehensive income attributable to the parent company was CNY 44,395,669.73, up from CNY 30,377,354.66, reflecting a growth of 46.2%[35] Cash Flow and Liquidity - Cash and cash equivalents increased by 197.33% to CNY 48.73 million, driven by improved cash flows from operating, investing, and financing activities[23] - Cash flow from operating activities generated a net cash inflow of CNY 166,421,600.28, compared to CNY 82,577,692.15 in the previous period, marking a growth of 101.5%[36] - Cash and cash equivalents at the end of the period reached CNY 1,239,782,600.47, up from CNY 664,071,039.75, indicating an increase of 86.5%[38] - The net cash outflow from investing activities was CNY -10,891,179.59, an improvement from CNY -172,218,066.11 in the previous period[37] - The net cash inflow from financing activities was CNY 403,259.29, a recovery from a net outflow of CNY -71,985,957.99 in the previous period[38] Research and Development - Research and development expenses increased by 130.08% to CNY 60.00 million, reflecting higher investment in R&D[14] - Research and development expenses rose significantly to ¥6,036,475.71 from ¥2,623,635.13, an increase of approximately 130.5%[34] Shareholder Information - The total number of common shareholders at the end of the reporting period is 113,342, with no preferred shareholders having restored voting rights[24] - The largest shareholder, Beingmate Group Co., Ltd., holds 12.28% of the shares, amounting to 132,629,471 shares, with 98.85% of its holdings (131,105,171 shares) pledged or frozen[26] - The second-largest shareholder, Changhong Investment Fund, holds 2.03% of the shares, totaling 21,969,300 shares[24] - The top ten shareholders collectively hold a significant portion of the company's shares, with the largest ten shareholders accounting for a substantial percentage of the total equity[25] - The company has not disclosed any changes in the participation of the top ten shareholders in margin financing and securities lending activities[25] Legal and Regulatory Matters - The company has experienced judicial freezes on shares held by its controlling shareholder due to legal disputes, affecting a total of 44,200 shares and 36,969,743 shares[26] - The company plans to implement new accounting standards starting from 2025, which may impact financial reporting[39] Strategic Initiatives - The company supports the establishment of an industrial incubation fund by its controlling shareholder's subsidiary, aiming to enhance investment risk management and strategic alignment[27] - As of the announcement date, the industrial fund's registration procedures have not been completed, and the company will disclose significant developments related to the fund[27] - The company is focused on expanding its market presence and developing new products within its maternal and infant ecosystem strategy[27] - The company is committed to ensuring the interests of all shareholders, particularly minority shareholders, in any future acquisitions related to the incubation fund[27]
贝因美(002570) - 2024 Q4 - 年度财报
2025-04-28 19:15
Industry Risks and Challenges - The infant formula industry faces risks such as declining newborn numbers, intense brand competition, and high operational costs, prompting the company to leverage existing resources to expand market share and enhance cost management [5]. - The company plans to strengthen accounts receivable collection and improve asset liquidity management to mitigate financial risks associated with high liquidity requirements in the consumer goods sector [6]. - The company emphasizes product quality control throughout the production process to address food safety risks, ensuring compliance with its quality policy [7][8]. - The company is focused on improving asset management to reduce potential liquidity risks in future operations [6]. - The company’s strategic focus includes market expansion and the development of new products and technologies to enhance its market position [5]. Financial Performance - The company's operating revenue for 2024 reached ¥2,773,430,491.70, representing a 9.70% increase compared to ¥2,528,157,007.97 in 2023 [24]. - The net profit attributable to shareholders for 2024 was ¥102,935,320.60, a significant increase of 116.92% from ¥47,453,066.89 in 2023 [24]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥79,306,120.65, up 334.44% from ¥18,254,814.31 in 2023 [24]. - The net cash flow from operating activities for 2024 was ¥497,416,870.03, an increase of 20.28% compared to ¥413,551,954.78 in 2023 [24]. - Basic earnings per share for 2024 were ¥0.10, a 150.00% increase from ¥0.04 in 2023 [24]. - Total assets at the end of 2024 were ¥4,041,710,691.26, reflecting a 0.99% increase from ¥3,900,099,864.43 at the end of 2023 [24]. - The net assets attributable to shareholders decreased by 1.59% to ¥1,565,669,995.95 at the end of 2024 from ¥1,590,911,074.60 at the end of 2023 [24]. Operational Adjustments and Strategies - The company will not distribute cash dividends, issue bonus shares, or increase capital through reserves [9]. - The company has classified certain properties as "investment properties," which will be adjusted to "fixed assets" and "intangible assets" due to non-compliance with accounting standards [26]. - The company has completed a full industry chain layout, integrating research, production, and sales [40]. - The company is focusing on expanding its product categories, including children's powder, adult powder, diapers, and wet wipes [46]. - The company has established a strong research and development capability, with 45 registered infant formula products and 4 special medical purpose formula products, enhancing its product portfolio and market competitiveness [62]. Market and Product Development - The company achieved a total revenue of 2.773 billion yuan in the reporting period, representing a 9.7% increase compared to the previous year [46]. - Revenue from infant formula reached 2.508 billion yuan, reflecting a growth of 7.33% year-on-year [46]. - The company is actively exploring strategic partnerships and collaborations to optimize its product structure and increase production capacity, focusing on ODM and OEM business models [50]. - The company has completed the registration of all infant formula products under the new national standards, enhancing its competitive edge in product innovation and compliance [50]. - The company is focusing on developing functional health products, including A2 milk and hydrolyzed whey protein, to enhance product quality and meet market demands [86]. Governance and Management - The company is committed to improving its governance structure and enhancing transparency in information disclosure to protect the rights of investors [122]. - The company has developed a market value management system and disclosed its valuation enhancement plan [120]. - The company held four shareholder meetings during the reporting period, ensuring equal treatment of all shareholders and compliance with relevant regulations [123]. - The board of directors convened nine meetings, with a composition of 8 members, including 3 independent directors, adhering to legal and regulatory requirements [125]. - The company has established a transparent performance evaluation and incentive mechanism for senior management, ensuring compliance with legal standards [129]. Employee and Compensation Structure - The company has implemented an employee stock ownership plan, with 782 employees holding a total of 8,380,030 shares, representing 0.78% of the company's total equity [166]. - The employee stock ownership plan was executed at a price of ¥2.18 per share, with a total grant expense of ¥17,430,462.36, to be amortized over a 12-month lock-up period [168]. - The company has maintained a consistent compensation structure for senior management, adhering to the 2022 management guidelines [148]. - The total number of employees at the end of the reporting period is 1,942, with 787 in the parent company and 1,155 in major subsidiaries [159]. - The professional composition includes 724 production personnel, 806 sales personnel, 308 technical personnel, 39 financial personnel, and 65 administrative personnel [159]. Related Party Transactions and Commitments - The company is involved in various related party transactions, including procurement of goods and services, which are priced at fair market value [198]. - The company has reported a high percentage of related party transactions, indicating a strong reliance on its controlling shareholder for operational needs [198]. - The actual controller, Mr. Xie Hong, has committed to not engaging in any competitive business activities with the company or its subsidiaries [183]. - Beiyinmei Group will not support any third parties in engaging in competitive activities with the company [183]. - The commitments made by Beiyinmei Group and Mr. Xie Hong are intended to avoid any conflicts of interest and ensure the company's interests are protected [182][183].
贝因美(002570) - 2023 Q4 - 年度财报(更正)
2025-04-28 19:15
Financial Performance - The company's operating revenue for 2023 was approximately ¥2.53 billion, representing a 0.76% increase compared to ¥2.51 billion in 2022[22]. - The net profit attributable to shareholders for 2023 was approximately ¥47.45 million, a significant turnaround from a loss of ¥176 million in 2022, marking a 126.97% improvement[22]. - The net cash flow from operating activities increased by 9.57% to approximately ¥413.55 million in 2023, up from ¥377.42 million in 2022[22]. - Basic and diluted earnings per share for 2023 were both ¥0.04, a 125% increase from a loss of ¥0.16 per share in 2022[22]. - Total assets at the end of 2023 were approximately ¥4.00 billion, reflecting a 3.23% increase from ¥3.88 billion at the end of 2022[22]. - The net assets attributable to shareholders increased by 3.40% to approximately ¥1.59 billion at the end of 2023, compared to ¥1.54 billion at the end of 2022[22]. - The company reported a total revenue of 11,550 million yuan from its subsidiary Beimei, with a net loss of 10,548 million yuan[95]. - The company reported a significant discrepancy between the net profit forecast and the actual results, leading to a transition from profit to loss[127]. Market and Product Development - The company reported a significant decline in newborn numbers, impacting the infant formula market, with intensified brand competition and high operational costs[4]. - The company is committed to expanding its market presence and sales scale by leveraging existing resources and advantages[4]. - The infant formula market is expected to see significant growth as demand shifts from first and second-tier cities to third and fourth-tier cities[40]. - The company continues to focus on R&D for new products, including special medical formula milk powder and various nutritional products[36]. - The company has completed the registration of all infant formula products under the new national standards[40]. - The company aims to enhance its brand image and expand into related product categories through partnerships and brand licensing[39]. - The company plans to expand its product matrix to meet the nutritional needs of adults and accelerate the research and industrialization of special medical purpose formula foods[97]. Operational Efficiency and Cost Management - The company plans to enhance cost management and expense control to improve competitiveness in the market[4]. - The company aims to strengthen the recovery of accounts receivable and improve asset liquidity management to mitigate financial risks[5]. - The company has implemented strategic procurement management, categorizing materials into four types to optimize supply chain efficiency[38]. - The company aims to enhance operational efficiency by optimizing its industrial layout and reducing operational costs[98]. - The company reported a decrease in operating costs to 1.338 billion yuan, down 1.46% year-on-year[53]. Governance and Compliance - The company adheres to strict governance practices, ensuring transparency and fairness in information disclosure to protect investor rights[105]. - The company ensures compliance with information disclosure regulations, providing timely and accurate information to shareholders through designated platforms[110]. - The company has established a fair and transparent performance evaluation and incentive mechanism for senior management[112]. - The company has implemented a system for insider information registration during the preparation of periodic reports[113]. - The company has revised its governance documents to align with the latest legal regulations, ensuring no significant discrepancies exist[114]. Social Responsibility and Environmental Compliance - The company emphasizes its commitment to providing high-quality products for children while promoting parent-child culture in families[162]. - The company has actively engaged in social responsibility initiatives, including support for special needs infants and disaster relief efforts[161]. - The company has implemented measures to ensure compliance with environmental protection laws and has achieved relevant certifications[159]. - The company’s subsidiaries are not classified as key pollutant discharge units by environmental authorities[159]. - The company recognizes its social responsibility in the baby and child industry, emphasizing love and care in its operations[162]. Shareholder and Management Structure - The company will not distribute cash dividends or issue bonus shares, nor will it increase share capital from reserves[7]. - The company has undergone multiple subsidiary cancellations, which had no significant impact on overall operations[96]. - The company has established a management method for senior management remuneration and assessment for 2022[130]. - The total number of employees at the end of the reporting period is 2,080, with 918 in the parent company and 1,162 in major subsidiaries[141]. - The company has a diverse management team with members holding various academic and professional qualifications, enhancing its operational capabilities[127]. Investment and Financial Activities - The company invested ¥390,000 to acquire a 39% stake in Hangzhou Yueligou Supermarket Co., Ltd. in April 2023[64]. - The company has committed to a project with an annual production capacity of 20,000 tons of formula milk, expected to be operational by 2024[88]. - The company has utilized 94.19 million yuan of self-raised funds for pre-investment in fundraising projects, which will be replaced by raised funds[89]. - The company has not engaged in any entrusted financial management during the reporting period[199]. - The total amount of external guarantees approved during the reporting period is CNY 175 million, with actual guarantees amounting to CNY 7.29 million[197].
贝因美(002570) - 年度股东大会通知
2025-04-28 19:14
证券代码:002570 证券简称:贝因美 公告编号:2025-031 贝因美股份有限公司 关于召开 2024 年度股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 贝因美股份有限公司(以下简称"公司")于 2025 年 4 月 27 日召开第九届董 事会第八次会议,审议通过《关于召开 2024 年度股东大会的议案》,同意于 2025 年 5 月 21 日召开公司 2024 年度股东大会。现将具体事宜公告如下: 一、召开会议的基本情况 1、会议届次:2024 年度股东大会 2、会议召集人:公司董事会 (1)现场会议召开时间:2025 年 5 月 21 日(星期三)下午 14:30 (2)网络投票时间:2025 年 5 月 21 日 其中,通过深圳证券交易所交易系统进行网络投票的具体时间为 2025 年 5 月 21 日 9:15-9:25,9:30-11:30,13:00-15:00;通过深圳证券交易所互联网投票系统进 行网络投票的具体时间为 2025 年 5 月 21 日 9:15 至 15:00 期间的任意时间。 5、会议召开方式: 络投票时间 ...
龙虎榜 贝因美下跌9.94%,一线游资东财拉萨金融城南环路卖出2052.20万元
Jin Rong Jie· 2025-04-28 10:06
本文源自:金融界 作者:智投君 东方财富证券股份有限公司拉萨团结路第一证券营业部、东方财富证券股份有限公司拉萨东环路第二证 券营业部、东方财富证券股份有限公司拉萨金融城南环路证券营业部分别卖出3069.01万元、2444.76万 元、2052.20万元。 买入金额最大的前5名营业部 买入额/万 卖出额/万 净额/万 机构专用 2650.72 1290.87 1359.85 东方财富 证券股份有限公司拉萨团结路第一证券营业部 2215.21 3069.01 -853.8 东方财富证券股份有限公司拉萨 东环路第二证券营业部 2139.25 2444.76 -305.51 东方财富证券股份有限公司拉萨金融城南环路证券营业 部 1930.37 2052.20 -121.83 国信证券股份有限公司浙江互联网分公司 1871.19 1698.57 172.62 卖出金额最 大的前5名营业部 买入额/万 卖出额/万 净额/万 东方财富证券股份有限公司拉萨团结路第一证券营业部 2215.21 3069.01 -853.8 东方财富证券股份有限公司拉萨东环路第二证券营业部 2139.25 2444.76 -305.51 东方财 ...
乳业概念下跌4.12%,主力资金净流出31股
Industry Overview - The dairy industry concept has seen a decline of 4.12%, ranking among the top sectors in terms of drop in value [1] - Major companies within the sector, such as Beiyinmei, have experienced significant losses, with Beiyinmei hitting the daily limit down [1] Market Performance - The dairy sector faced a net outflow of 640 million yuan from main funds today, with 31 stocks experiencing net outflows [2] - Beiyinmei led the outflow with 201 million yuan, followed by Yili Group with 117 million yuan and Dabeinong with 39.64 million yuan [2] Stock Performance - Beiyinmei's stock dropped by 9.94% with a turnover rate of 26.27% and a net outflow of 200.52 million yuan [2] - Other notable declines include: - Yili Group: -1.28% with a net outflow of 116.71 million yuan - Dabeinong: -1.46% with a net outflow of 39.64 million yuan - Wewei Co.: -8.84% with a net outflow of 37.92 million yuan [2][3]
龙虎榜 贝因美下跌10.04%,一线游资东财拉萨金融城南环路买入3572.55万元
Jin Rong Jie· 2025-04-25 09:28
4月25日,贝因美下跌10.04%登上龙虎榜,日跌幅偏离值达7%,一线游资买入。 龙虎榜显示,买入前五合计买入1.88亿元,卖出前五合计卖出3.63亿元,净额-1.76亿元。 机构专用、华林证券股份有限公司北京分公司、机构专用分别卖出11089.80万元、4446.03万元、 4193.11万元。 买入金额最大的前5名营业部 买入额/万 卖出额/万 净额/万 东方财富证券股份有限公司拉萨团结路第一 证券营业部 4367.90 2469.28 1898.62 东方财富证券股份有限公司拉萨东环路第二证券营业部 3618.35 1755.17 1863.18 东方财富证券股份有限公司拉萨金融城南环路证券营业部 3572.55 2657.40 915.15 国信 证券股份有限公司浙江互联网分公司 2592.64 1445.97 1146.67 东方财富证券股份有限公司拉萨东环路第 一证券营业部 2469.75 1668.92 800.83 卖出金额最大的前5名营业部 买入额/万 卖出额/万 净额/万 机构专 用 1455.58 11089.80 -9634.22 华林证券股份有限公司北京分公司 26.39 4446. ...
96只A股筹码大换手(4月24日)
证券时报·数据宝统计,截至(4月24日)收盘,沪指报3297.29点,涨0.93点,涨幅为0.03%;深成指报 9878.32点,跌57.48点,跌幅为0.58%;创业板指报1935.86点,跌13.30点,跌幅为0.68%。个股方面, 今日96只A股换手率超过20%,其中,C江顺科、C天有等5只个股换手率达五成以上,半数筹码易主。 (数据宝) 4月24日两市换手率居前个股一览 | 证券代码 | 证券简称 | 收盘价(元) | 换手率(%) | 涨跌幅(%) | | --- | --- | --- | --- | --- | | 001400 | C江顺科 | 66.70 | 72.39 | 78.53 | | 603202 | C天有 | 116.00 | 70.35 | 24.06 | | 920066 | 科拜尔 | 48.65 | 59.97 | -14.47 | | 002094 | 青岛金王 | 9.14 | 57.39 | 2.24 | | 603205 | 健尔康 | 43.75 | 53.69 | 10.01 | | 301277 | 新天地 | 13.27 | 48.54 | 3.75 | ...